Back

Validation of endothelin-1 as a predictor of adverse prognosis in coronary artery disease patients with impaired kidney function with or without diabetes

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Diabetes and coronary artery disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Zixiang Ye

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

6 More presentations in this session

Presentation thumbnail
Differential effects of glucose-lowering agents on atherosclerotic plaque progression in diabetic patients: a retrospective cohort study using serial coronary CT angiography
Doctor J. Zhang (Chengdu, CN)
Abstract Slides Video
Presentation thumbnail
Participant-level pericoronary adipose tissue attenuation predicts changes in plaque composition: a 1-year prospective study in asymptomatic individuals with type 2 diabetes mellitus
Doctor K. Overgaard (Svendborg, DK)
Abstract Slides Video
Presentation thumbnail
Glycemic control and renal function decline in patients with chronic coronary syndrome
Doctor C. HUANG (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Impact of prediabetes on long-term outcomes after percutaneous coronary interventions
Doctor E. Steinacher (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Diabetes status and grade of left ventricular ejection fraction as predictors of outcomes in patients with Non-ST-segment elevation myocardial infarction
Professor Y. Kim (Chuncheon, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes and coronary artery disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Prognostic impact of percutaneous coronary intervention in NSTEMI patients with different stages of chronic kidney disease: a multi-center retrospective study
thumbnail
Congress Presentation
Impact of worsening renal function (WRF) and baseline chronic kidney disease (CKD) on clinical outcomes in patients with chronic coronary syndromes (CCS); insights from the REAL-CAD study
thumbnail
Congress Presentation
Synergistic adverse impact of diabetes and chronic kidney disease on cardiovascular mortality in patients underwent percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources